Funding for this research was provided by:
Genentech
Article History
Accepted: 12 April 2023
First Online: 29 April 2023
Declarations
:
: PCT, is an employee of Genentech. TH is employed as a consultant (contractor) by Genentech. TP is on the speakers’ bureau for Pfizer and Genentech.
: The study was performed in line with the principles of the Declaration of Helsinki. Peter Trask is employed by Genentech and holds stock in Roche. Tracy Holt has no financial interests. Timothy Pearman has received speaker honorarium in the past from Genentech.
: Written informed consent was obtained from all participants of the original clinical trials. There is no personally identifiable information in the manuscript, and therefore consent to publish was not required.